ArticleJournal of cosmetic dermatology2026
Skin-Lightening Efficacy of Leatherleaf Fern Extract and a Leatherleaf Fern-Based Facial Serum In Vitro and Clinical Trial.
Article in Journal of cosmetic dermatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHyperpigmentation, caused by excessive melanin accumulation, is a significant cosmetic concern in dermatology. Natural compounds are receiving attention as safe and effective skin-lightening agents due to their antioxidant properties and ability to inhibit melanin synthesis.
aimsTo investigate the antioxidant and melanin biosynthesis inhibitory effects of leatherleaf fern water extract (LFWE) and the skin-lightening efficacy of a facial serum containing LFWE through in vitro and clinical trials: MATERIALS AND
methodsThe antioxidant and tyrosinase inhibitory activities of LFWE were confirmed in vitro, along with its inhibitory effects on factors involved in melanin biosynthesis. Its skin-lightening effects were then validated through clinical trials.
resultsLFWE demonstrated excellent 1,1-diphenyl-2-picrylhydrazyl and ABTS cation radical scavenging activity and inhibited mushroom tyrosinase activity in a concentration-dependent manner. LFWE also suppressed melanin biosynthesis in B16-F10 melanoma cells without toxicity up to 500 μg/mL and significantly inhibited the protein expression levels of tyrosinase, TRP-1, and TRP-2, which promote melanin production. Clinical trials of a serum containing LFWE showed that it reduced the melanin index after 4 and 8 weeks, thereby confirming its skin-lightening effects.
conclusionLFWE exerts excellent antioxidant effects and inhibits the expression of factors involved in melanin biosynthesis, thereby demonstrating skin-lightening effects. Moreover, LFWE-containing serum significantly reduced melanin indices in clinical trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.